AVITA Medical shareholders elect directors, approve equity awards at annual meeting

AVITA Medical, Inc.

All seven director nominees elected: Louis Panaccio, James Corbett, Jeremy Curnock Cook, Suzanne Crowe, Jan Stern Reed, Robert McNamara, Cary Vance.
Stockholders approved RSUs valued at $87,500 and options valued at $37,500 for each non-executive director.
CEO James Corbett granted options to acquire 350,000 shares of common stock, approved by shareholders.
Non-binding advisory vote on named executive officer compensation passed (10,269,125 for, 2,296,661 against).
Ratification of Grant Thornton LLP as independent auditor for FY2024 approved (14,794,234 for).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.